# Longitudinal neuroimaging in Sturge-Weber syndrome

> **NIH NIH R01** · WAYNE STATE UNIVERSITY · 2021 · $392,494

## Abstract

PROJECT SUMMARY
Sturge-Weber syndrome (SWS) is a sporadic neurocutaneous disorder characterized by a facial port-wine
birthmark and leptomeningeal vascular malformation (LVM). SWS most often (85%) affects one cerebral
hemisphere and has a progressive but highly variable clinical course, thus providing a unique clinical model to
study the neurocognitive effects of an early, postnatal, unilateral brain lesion. Most children with SWS develop
seizures during the first 2 years of life and also develop neurological symptoms as well as cognitive
impairment. Currently, SWS has no cure or specific treatment. With NIH support and nationwide patient
recruitment, we have built a clinical imaging research program for children with SWS, in order to understand
the pathophysiology of progression and find new diagnostic and treatment paradigms. We have tested novel
MRI approaches for more accurate detection of SWS-related brain abnormalities and identified critical age
windows when most of the progressive brain damage occurs. Recently, we have also identified two, potentially
powerful compensatory mechanisms that may prevent severe neurocognitive complications of SWS-related
brain injury: (i) a deep venous vascular remodeling in the ipsilateral (SWS-affected) hemisphere, and (ii)
reorganization in the contralateral hemisphere affecting both verbal and non-verbal cognitive functions. We
also identified a subgroup of children with SWS whose cognitive functions improved over time, presumably due
to effective compensatory processes. In Aim 1 of this renewal proposal, we will test the application of a
recently developed rapid MRI protocol (called STAGE) for safe and accurate early screening and late follow-up
of brain vascular and parenchymal abnormalities. This new, innovative imaging approach is widely applicable
and could change clinical practice for SWS imaging, used as a screening technique in preventive trials, and be
utilized in other pediatric neurological diseases. In Aim 2, we will extend our previous studies to older children
and young adults with SWS to use susceptibility-weighted imaging and diffusion tensor imaging connectivity
studies to evaluate the role of vascular remodeling and structural brain reorganization, respectively, in the
preservation and reorganization of motor symptoms and specific cognitive functions that can be targeted by
interventions. In Aim 3, we will use SWS epilepsy surgical tissue to harvest cells from both the LVM and
various parenchymal cells and utilize a laser capture microdissection approach to identify specific cell types
harboring the somatic GNAQ mutation. We will also study the imaging correlates and associated protein
changes associated with dysregulated angiogenesis. The expected findings could fundamentally shape our
concept as to how this mutation can lead to brain pathology and will also identify novel treatment targets.

## Key facts

- **NIH application ID:** 10113671
- **Project number:** 5R01NS041922-16
- **Recipient organization:** WAYNE STATE UNIVERSITY
- **Principal Investigator:** CSABA JUHASZ
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $392,494
- **Award type:** 5
- **Project period:** 2003-07-01 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10113671

## Citation

> US National Institutes of Health, RePORTER application 10113671, Longitudinal neuroimaging in Sturge-Weber syndrome (5R01NS041922-16). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10113671. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
